As the Associate Director of Real World Value & Evidence in Oncology at Johnson & Johnson, Shawn Du plays a pivotal role in shaping the strategic landscape of real-world evidence (RWE) research within the life sciences sector. With a focus on solid tumors, particularly lung...
As the Associate Director of Real World Value & Evidence in Oncology at Johnson & Johnson, Shawn Du plays a pivotal role in shaping the strategic landscape of real-world evidence (RWE) research within the life sciences sector. With a focus on solid tumors, particularly lung and prostate cancer, Shawn has successfully built and led a comprehensive US RWE research strategy that underpins the value proposition for Erleada, a leading treatment for prostate cancer. His expertise in data science and health economics outcomes research (HEOR) allows him to generate competitive and differentiating real-world data that informs both commercial and medical strategies.
Shawn's leadership in executing data-driven projects has not only enhanced the understanding of treatment impacts in real-world settings but has also facilitated the development of core value propositions essential for product launches. By leveraging advanced data analysis and statistical methodologies, he has been able to translate complex data into actionable insights that resonate with stakeholders across the healthcare continuum. His ability to manage cross-functional teams and foster client relations has been instrumental in driving successful collaborations that enhance the visibility and credibility of RWE initiatives.
In his role, Shawn is at the forefront of integrating real-world data into clinical decision-making processes, ensuring that the voice of the patient is heard and valued. His commitment to advancing oncology research through innovative RWE strategies positions him as a thought leader in the field, dedicated to improving patient outcomes and informing healthcare policies. As he continues to navigate the evolving landscape of oncology, Shawn remains focused on harnessing the power of real-world evidence to deliver meaningful insights that drive value for patients and healthcare providers alike.
